TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | -1 | -20 | -29 | -14 | -64 | -21 |
| P | %wins | 100 | 0 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/8/21 16:15 | 5/8/20 | AYLA | Ayala Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sidransky David | L3 | D | P.m | 4 | 14.80 | 0 | 0 | New | 0 | I | |||||||||||||||
1/11/21 14:12 | 5/7/20 | ORGS | Orgenesis Inc. | NV | Health | Drug | Pharmaceutical Preparations | Sidransky David | MD | D | P.m | 1 | 5.96 | 0 | 0 | New | 0 | I | |||||||||||||||
12/3/14 16:54 | 11/26/14 | IMNP | Immune Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Sidransky David | MA | D | P.d | 26 | 2.50 | 0 | 10 | 132 | 18 | D | -18 | 49 | 3 | -28 | -11 | -9 | 2 | 0 | 2 | -1 | -20 | -29 | -14 | -64 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |